[1]
|
Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.
https://doi.org/10.3322/caac.21492
|
[2]
|
Mantovani, A., Allavena, P., Sica, A., et al. (2008) Cancer-Related In-flammation. Nature, 454, 436-444.
https://doi.org/10.1038/nature07205
|
[3]
|
Ng, S.P., Bahig, H., Jethanandani, A., et al. (2021) Prognostic Signifi-cance of Pre-Treatment Neutrophil-to-Lymphocyte Ratio (NLR) in Patients with Oropharyngeal Cancer Treated with Ra-diotherapy. British Journal of Cancer, 124, 628-633. https://doi.org/10.1038/s41416-020-01106-x
|
[4]
|
Balkwill, F. and Mantovani, A. (2001) Inflammation and Cancer: Back to Virchow. The Lancet, 357, 539-545.
https://doi.org/10.1016/S0140-6736(00)04046-0
|
[5]
|
Freisinger, C.M., Huttenlocher, A. (2014) Live Imaging and Gene Expression Analysis in Zebrafish Identifies a Link between Neutrophils and Epithelial to Mesenchymal Transition. PLOS ONE, 9, e112183.
https://doi.org/10.1371/journal.pone.0112183
|
[6]
|
Coffelt, S.B., Wellenstein, M.D. and de Visser, K.E. (2016) Neutrophils in Cancer: Neutral No More. Nature Reviews Cancer, 16, 431-446. https://doi.org/10.1038/nrc.2016.52
|
[7]
|
Rakic, A., Beaudry, P. and Mahoney, D.J. (2018) The Complex Interplay between Neutrophils and Cancer. Cell and Tissue Research, 371, 517-529. https://doi.org/10.1007/s00441-017-2777-7
|
[8]
|
Schernberg, A., Blanchard, P., Chargari, C. and Deutsch, E. (2017) Neutrophils, a Candidate Biomarker and Target for Radiation Therapy. Acta Oncologica, 56, 1522-1530. https://doi.org/10.1080/0284186X.2017.1348623
|
[9]
|
Qin, F., Liu, X., Chen, J., et al. (2020) Anti-TGF-β Attenu-ates Tumor Growth via Polarization of Tumor Associated Neutrophils towards an Anti-Tumor Phenotype in Colorectal Cancer. Journal of Cancer, 11, 2580-2592.
https://doi.org/10.7150/jca.38179
|
[10]
|
Lee, H.J., Kim, J.M., Chin, Y.J., et al. (2020) Prognostic Value of Hemato-logical Parameters in Locally Advanced Cervical Cancer Patients Treated with Concurrent Chemoradiotherapy. Anti-cancer Research, 40, 451-458.
https://doi.org/10.21873/anticanres.13973
|
[11]
|
Eren, T., Karacin, C., Ucar, G., et al. (2020) Correlation between Peripheral Blood Inflammatory Indicators and Pathologic Complete Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients. Medicine (Baltimore), 99, e20346. https://doi.org/10.1097/MD.0000000000020346
|
[12]
|
Colloca, G.A., Venturino, A. and Guarneri, D. (2019) Neu-trophil-Related Variables Have Different Prognostic Effect Based on Primary Tumor Location in Patients with Metastatic Colorectal Cancer Receiving Chemotherapy. Clinical Colorectal Cancer, 18, e343-e348. https://doi.org/10.1016/j.clcc.2019.06.007
|
[13]
|
Ohms, M., Möller, S. and Laskay, T. (2020) An Attempt to Polarize Human Neutrophils toward N1 and N2 Phenotypes in Vitro. Frontiers in Immunology, 11, 532. https://doi.org/10.3389/fimmu.2020.00532
|
[14]
|
Watanabe, J., Saito, M., Horimoto, Y. and Nakamoto, S. (2020) A Maintained Absolute Lymphocyte Count Predicts the Overall Survival Benefit from Eribulin Therapy, Including Eribulin Re-Administration, in HER2-Negative Advanced Breast Cancer Patients: A Single-Institutional Experience. Breast Can-cer Research and Treatment, 181, 211-220.
https://doi.org/10.1007/s10549-020-05626-1
|
[15]
|
Karantanos, T., Karanika, S., Seth, B. and Gignac, G. (2019) The Absolute Lymphocyte Count Can Predict the Overall Survival of Patients with Non-Small Cell Lung Cancer on Nivolumab: A Clinical Study. Clinical and Translational Oncology, 21, 206-212. https://doi.org/10.1007/s12094-018-1908-2
|
[16]
|
Noh, B.J., Kwak, J.Y. and Eom, D.W. (2020) Immune Classifica-tion for the PD-L1 Expression and Tumour-Infiltrating Lymphocytes in Colorectal Adenocarcinoma. BMC Cancer, 20, 58.
https://doi.org/10.1186/s12885-020-6553-9
|
[17]
|
Fuchs, T.L., Pearson, A., Pickett, J., et al. (2020) Why Pathologists and Oncologists Should Know about Tumour-Infiltrating Lymphocytes (TILs) in Triple-Negative Breast Cancer: An Australian Experience of 139 Cases. Pathology, 52, 515-521. https://doi.org/10.1016/j.pathol.2020.04.004
|
[18]
|
Metelli, A., Salem, M., Wallace, C.H., et al. (2018) Immunoreg-ulatory Functions and the Therapeutic Implications of GARP-TGF-β in Inflammation and Cancer. Journal of Hematology & Oncology, 11, 24.
https://doi.org/10.1186/s13045-018-0570-z
|
[19]
|
Pasche, B. (2012) Aspirin—From Prevention to Targeted Therapy. The New England Journal of Medicine, 367, 1650-1651. https://doi.org/10.1056/NEJMe1210322
|
[20]
|
辛衡, 周建平, 高威, 董明. 结直肠癌患者术前血浆纤维蛋白原、癌胚抗原、糖类抗原19-9水平与临床病理特征的关系[J]. 中国医科大学学报, 2020, 49(11): 1007-1010.
|
[21]
|
Wu, M., Pan, Y., Jia, Z., et al. (2019) Preoperative Plasma Fibrin-ogen and Serum Albumin Score Is an Independent Prognostic Factor for Resectable Stage II-III Gastric Cancer. Disease Markers, 2019, Article ID: 9060845.
https://doi.org/10.1155/2019/9060845
|
[22]
|
Forrest, L.M., McMillan, D.C., McArdle, C.S., et al. (2005) A Pro-spective Longitudinal Study of Performance Status, an Inflammation-Based Score (GPS) and Survival in Patients with Inoperable Non-Small-Cell Lung Cancer. British Journal of Cancer, 92, 1834-1836. https://doi.org/10.1038/sj.bjc.6602591
|
[23]
|
Shibutani, M., Maeda, K., Nagahara, H., et al. (2015) The Prognostic Significance of a Postoperative Systemic Inflammatory Response in Patients with Colorectal Cancer. World Journal of Surgical Oncology, 13, 194.
https://doi.org/10.1186/s12957-015-0609-3
|
[24]
|
Singh, S., Singh, J., Ganguly, R., et al. (2021) Diagnostic Effica-cy of Neutrophil to Lymphocyte Ratio (NLR) in Oral Potentially Malignant Disorders and Oral Cancer. Indian Journal of Pathology and Microbiology, 64, 243-249.
|
[25]
|
Fujii, T., Sutoh, T., Morita, H., et al. (2012) Serum Albumin Is Superi-or to Prealbumin for Predicting Short-Term Recurrence in Patients with Operable Colorectal Cancer. Nutrition and Can-cer, 64, 1169-1173.
https://doi.org/10.1080/01635581.2012.718034
|
[26]
|
李晶晶, 钟春生. 血小板与肿瘤相关性研究进展[J]. 现代肿瘤医学, 2017, 25(23): 3896-3900.
|
[27]
|
夏志刚, 甘志明, 向立历, 阳川华, 汪晓东, 李立. NLR和PLR与结直肠癌患者TNM分期及预后的相关性研究[J]. 中国普外基础与临床杂志, 2017, 24(8): 963-969.
|
[28]
|
Shirai, Y., Shiba, H., Sakamoto, T., et al. (2015) Preoperative Platelet to Lymphocyte Ratio Predicts Outcome of Patients with Pancreatic Ductal Adenocarcinoma after Pancreatic Resection. Surgery, 158, 360-365.
https://doi.org/10.1016/j.surg.2015.03.043
|
[29]
|
Fang, T., Wang, Y., Yin, X., et al. (2020) Diagnostic Sensitivity of NLR and PLR in Early Diagnosis of Gastric Cancer. Journal of Immunology Research, 2020, Article ID: 9146042. https://doi.org/10.1155/2020/9146042
|
[30]
|
Chen, C., Liu, Y., Han, P. and Cui, B. (2021) Research Progress of Preoperative FPR, FAR or AFR in Patients with Colorectal Cancer. Cancer Management and Research, 13, 1791-1801. https://doi.org/10.2147/CMAR.S292605
|
[31]
|
Sun, F., Tan, Y.A., Gao, Q.F., et al. (2019) Circulating Fibrinogen to Pre-Albumin Ratio Is a Promising Biomarker for Diagnosis of Colorectal Cancer. Journal of Clinical Laboratory Analysis, 33, e22635.
https://doi.org/10.1002/jcla.22635
|